Some pharmaceutical companies are well into the final phase of clinical trials for a coronavirus vaccine. But efforts to recruit patients from minority groups are just beginning.
The COVID-19 special session last three days last week to handle a myriad of issues related to the virus, and didn't wrap up until the wee hours of Saturday morning.